[Research progress on in vitro effects of traditional Chinese medicine ingredients on liver UDP-glucuronosyltransferases]
- PMID: 39701723
- DOI: 10.19540/j.cnki.cjcmm.20240709.201
[Research progress on in vitro effects of traditional Chinese medicine ingredients on liver UDP-glucuronosyltransferases]
Abstract
UDP-glucuronosyltransferases(UGTs) are the main phase Ⅱ metabolizing enzymes in the human body, participating in the glucuronidation of various chemicals in the body. Traditional Chinese medicine(TCM) ingredients affect the activities of UGTs involved in drug metabolism, and the fluctuations in the blood concentrations of drugs metabolized by UGTs will lead to the risk of TCM-TCM or TCM-chemical drug interaction, which will cause drug safety problems and affect drug efficacy. Therefore, it is essential to explore the effect of TCM ingredients on the activities of UGTs. The recombinant human UGTs method and liver microsomal incubation method are reliable and effective, and they are thus often used to study the effects of TCM ingredients on UGTs in the liver. Studies have reported that different TCM ingredients can induce or inhibit the activities of UGTs, while the systematical review remains to be carried out. This paper reviews the effects of different ingredients and extracts of TCM and Chinese patent medicines on recombinant human UGTs or liver microsomal UGTs, aiming to provide reference for the rational and safe use of TCM in clinical practice. From the perspective of drug-drug interaction mediated by UGTs, the exacting classical drug pairs and incompatibility principles of traditional Chinese medicine were clarified, which laid the foundation for exploring new drug compatibility.
Keywords: UDP-glucuronosyltransferases(UGTs); liver microsome; recombinant human UGTs; traditional Chinese medicine.
Similar articles
-
[Advances in research on regulatory effects of chemical ingredients of traditional Chinese medicine on UDP-glucuronosyltransferase 1A1 expression and activity].Zhongguo Zhong Yao Za Zhi. 2017 Feb;42(3):428-432. doi: 10.19540/j.cnki.cjcmm.2017.0008. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 28952244 Review. Chinese.
-
Identification of human UDP-glucuronosyltransferases involved in I3,II8-biapigenin glucuronidation in Vitro.J Pharm Biomed Anal. 2025 Jun 15;258:116735. doi: 10.1016/j.jpba.2025.116735. Epub 2025 Feb 4. J Pharm Biomed Anal. 2025. PMID: 39923326
-
Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases.J Ethnopharmacol. 2020 Mar 25;250:112528. doi: 10.1016/j.jep.2019.112528. Epub 2019 Dec 26. J Ethnopharmacol. 2020. PMID: 31884038
-
Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.Drug Metab Dispos. 2015 Jun;43(6):812-8. doi: 10.1124/dmd.114.062141. Epub 2015 Apr 1. Drug Metab Dispos. 2015. PMID: 25834030
-
The advancement of targeted regulation of hepatic stellate cells using traditional Chinese medicine for the treatment of liver fibrosis.J Ethnopharmacol. 2025 Feb 11;341:119298. doi: 10.1016/j.jep.2024.119298. Epub 2025 Jan 10. J Ethnopharmacol. 2025. PMID: 39798676 Review.